338 related articles for article (PubMed ID: 34219226)
1. Hypermobile Ehlers-Danlos syndrome: A review and a critical appraisal of published genetic research to date.
Scicluna K; Formosa MM; Farrugia R; Borg I
Clin Genet; 2022 Jan; 101(1):20-31. PubMed ID: 34219226
[TBL] [Abstract][Full Text] [Related]
2. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
Martin A
Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for Ehlers-Danlos Syndromes: There Is a Role?
Caliogna L; Guerrieri V; Annunziata S; Bina V; Brancato AM; Castelli A; Jannelli E; Ivone A; Grassi FA; Mosconi M; Pasta G
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576312
[TBL] [Abstract][Full Text] [Related]
4. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
[TBL] [Abstract][Full Text] [Related]
5. Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome.
Forghani I
Balkan Med J; 2019 Jan; 36(1):12-16. PubMed ID: 30063214
[TBL] [Abstract][Full Text] [Related]
6. Genetic complexity of diagnostically unresolved Ehlers-Danlos syndrome.
Vandersteen AM; Weerakkody RA; Parry DA; Kanonidou C; Toddie-Moore DJ; Vandrovcova J; Darlay R; Santoyo-Lopez J; Meynert A; ; Kazkaz H; Grahame R; Cummings C; Bartlett M; Ghali N; Brady AF; Pope FM; van Dijk FS; Cordell HJ; Aitman TJ
J Med Genet; 2024 Feb; 61(3):232-238. PubMed ID: 37813462
[TBL] [Abstract][Full Text] [Related]
7. Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.
Gensemer C; Burks R; Kautz S; Judge DP; Lavallee M; Norris RA
Dev Dyn; 2021 Mar; 250(3):318-344. PubMed ID: 32629534
[TBL] [Abstract][Full Text] [Related]
8. Skin biopsy reveals generalized small fibre neuropathy in hypermobile Ehlers-Danlos syndromes.
Igharo D; Thiel JC; Rolke R; Akkaya M; Weis J; Katona I; Schulz JB; Maier A
Eur J Neurol; 2023 Mar; 30(3):719-728. PubMed ID: 36437696
[TBL] [Abstract][Full Text] [Related]
9. Predictors of pain and mobility disability in the hypermobile Ehlers-Danlos syndrome.
Kalisch L; Hamonet C; Bourdon C; Montalescot L; de Cazotte C; Baeza-Velasco C
Disabil Rehabil; 2020 Dec; 42(25):3679-3686. PubMed ID: 31060411
[No Abstract] [Full Text] [Related]
10. The role of gene encoding collagen secretion protein (SERPINH1) in the pathogenesis of a hypermobile type of Ehlers-Danlos syndrome.
Junkiert-Czarnecka A; Pilarska-Deltow M; Bąk A; Heise M; Haus O
Postepy Dermatol Alergol; 2023 Feb; 40(1):102-106. PubMed ID: 36909907
[TBL] [Abstract][Full Text] [Related]
11. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
Thwaites PA; Gibson PR; Burgell RE
J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
[TBL] [Abstract][Full Text] [Related]
12. The Ehlers-Danlos syndromes, rare types.
Brady AF; Demirdas S; Fournel-Gigleux S; Ghali N; Giunta C; Kapferer-Seebacher I; Kosho T; Mendoza-Londono R; Pope MF; Rohrbach M; Van Damme T; Vandersteen A; van Mourik C; Voermans N; Zschocke J; Malfait F
Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):70-115. PubMed ID: 28306225
[TBL] [Abstract][Full Text] [Related]
13. Some cases of hypermobile Ehlers-Danlos syndrome may be rooted in mast cell activation syndrome.
Afrin LB
Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):466-472. PubMed ID: 34719842
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary chronic pain management strategies in patients with Ehlers-Danlos syndromes.
Gullapalli PA; Javed S
Pain Manag; 2023 Jan; 13(1):5-14. PubMed ID: 36305215
[TBL] [Abstract][Full Text] [Related]
15. Temporomandibular disorders among Ehlers-Danlos syndromes: a narrative review.
Oelerich O; Daume L; Yekkalam N; Hanisch M; Menne MC
J Int Med Res; 2024 Apr; 52(4):3000605241242582. PubMed ID: 38603608
[TBL] [Abstract][Full Text] [Related]
16. The 2017 international classification of the Ehlers-Danlos syndromes.
Malfait F; Francomano C; Byers P; Belmont J; Berglund B; Black J; Bloom L; Bowen JM; Brady AF; Burrows NP; Castori M; Cohen H; Colombi M; Demirdas S; De Backer J; De Paepe A; Fournel-Gigleux S; Frank M; Ghali N; Giunta C; Grahame R; Hakim A; Jeunemaitre X; Johnson D; Juul-Kristensen B; Kapferer-Seebacher I; Kazkaz H; Kosho T; Lavallee ME; Levy H; Mendoza-Londono R; Pepin M; Pope FM; Reinstein E; Robert L; Rohrbach M; Sanders L; Sobey GJ; Van Damme T; Vandersteen A; van Mourik C; Voermans N; Wheeldon N; Zschocke J; Tinkle B
Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):8-26. PubMed ID: 28306229
[TBL] [Abstract][Full Text] [Related]
17. COL1A1 and COL1A2 variants in Ehlers-Danlos syndrome phenotypes and COL1-related overlap disorder.
Venable E; Knight DRT; Thoreson EK; Baudhuin LM
Am J Med Genet C Semin Med Genet; 2023 Jun; 193(2):147-159. PubMed ID: 36896471
[TBL] [Abstract][Full Text] [Related]
18. The Many Facets of Hypermobile Ehlers-Danlos Syndrome.
Riley B
J Am Osteopath Assoc; 2020 Jan; 120(1):30-32. PubMed ID: 31904772
[TBL] [Abstract][Full Text] [Related]
19. Molecular Genetics and Pathogenesis of Ehlers-Danlos Syndrome and Related Connective Tissue Disorders.
Ritelli M; Colombi M
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32414079
[TBL] [Abstract][Full Text] [Related]
20. Biological insights in the pathogenesis of hypermobile Ehlers-Danlos syndrome from proteome profiling of patients' dermal myofibroblasts.
Chiarelli N; Zoppi N; Ritelli M; Venturini M; Capitanio D; Gelfi C; Colombi M
Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166051. PubMed ID: 33383104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
